Thursday, November 3, 2011

TEVA - Adjustment

The following adjustment was made today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.

CriteriaValue
Dividend Champions StatusContender
Years of Consecutive Dividend Increases12
Fair Value Estimate$63.00
Target Buy Price$45.00
Target Margin of Safety28.57%
Actual Buy Price$45.00
Actual Margin of Safety28.57%

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
11/3/2011TEVAContinued TradeSTO 1 Jan12 45.00 Call @ 0.91  $91.13

Current Position Summary

Cost Basis($4,500.00)
Income Generated$214.11
Percent Income Generated4.76%
Annualized Income Generated7.18%
Net Profit If Assigned$214.11
Percent Return If Assigned4.76%
Annualized Return If Assigned7.18%
Days Held to Expiration242 days

Trade History

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
5/23/2011TEVACSP Margin UsedCSP 100 TEVA @ 45.00 ($4,500.00) 
5/23/2011TEVAInitial Put OptionSTO 1 Sep11 45.00 Put @ 1.23Exercised $122.98
9/16/2011TEVACSP Margin ReturnedCSP 100 TEVA @ -45.00 $4,500.00 
9/16/2011TEVAStock AssignedEX 1 Sep11 45.00 Put @ -45.00 ($4,500.00) 
11/3/2011TEVAContinued TradeSTO 1 Jan12 45.00 Call @ 0.91  $91.13
1/20/2012TEVA Totals ($4,500.00)$214.11
DTE242 Percent Income/Annualized 4.76%7.18%